Paid Clinical Trials Fort Wayne
Discover 105 paid clinical trials in Fort Wayne, Indiana. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
VITRAKVIStudy to Learn More About the Safety and Effectiveness of the Drug VITRAKVI During Routine Use in Patients With TRK Fusion Cancer Which is Locally Advanced or Spread From the Place Where it Started to Other Places in the Body
Sponsor:
Bayer
Location:
Code:
NCT04142437
Conditions
Locally Advanced or Metastatic Solid Tumor Harboring an NTRK Gene Fusion
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
larotrectinib(Vitrakvi, BAY2757556)
ABBV-383A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma
Sponsor:
TeneoOne Inc.
Location:
Code:
NCT05650632
Conditions
Multiple Myeloma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ABBV-383
Venetoclax with cBTKiA Study to Evaluate the Effect of Venetoclax on Participants Receiving a Covalent Bruton's Tyrosine Kinase Inhibitor (cBTKi) for First-Line Chronic Lymphocytic Leukemia (1L CLL) to Achieve Deep Durable Remissions to Allow Off-Treatment Period.
Sponsor:
Genentech, Inc.
Location:
Code:
NCT06524375
Conditions
Chronic Lymphocytic Leukemia
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Venetoclax
cBTKi Monotherapy
Nemtabrutinib vs. Ibrutinib & AcalabrutinibA Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line (1L) Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) (MK-1026-011/BELLWAVE-011)
Sponsor:
Merck Sharp & Dohme LLC
Location:
Code:
NCT06136559
Conditions
Chronic Lymphocytic Leukemia
Small Lymphocytic Lymphoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Nemtabrutinib
Ibrutinib
Acalabrutinib
Interested in new trials?
Get alerts for new trials in your area by subscribing now
BostonGene & ExigentBostonGene and Exigent Genomic INsight Study
Sponsor:
BostonGene
Location:
Code:
NCT06272864
Conditions
Breast Cancer
Non-small Cell Lung Cancer
Melanoma
Sarcoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Neoadjuvant Chemotherapy & TrastuzumabStudy of Neoadjuvant Chemotherapy Plus Trastuzumab and Pertuzumab in HER2-Negative Breast Cancer Patients With Abnormal HER2 Signaling
Sponsor:
NSABP Foundation Inc
Location:
Code:
NCT03412643
Conditions
HER2-negative Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Doxorubicin
Cyclophosphamide
Weekly Paclitaxel
Trastuzumab
Pertuzumab
BION-1301A Study of Zigakibart in Adults With IgA Nephropathy
Sponsor:
Chinook Therapeutics, Inc.
Location:
Code:
NCT05852938
Conditions
IgA Nephropathy
Immunoglobulin A Nephropathy
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
BION-1301
Placebo
ABBV-514 & BudigalimabStudy to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer (NSCLC), Head and Neck Squamous Cell Carcinoma (HNSCC) and Other Solid Tumors, Receiving Intravenous (IV) Infusion of ABBV-514 Alone or in Combination With Budigalimab
Sponsor:
AbbVie
Location:
Code:
NCT05005403
Conditions
Non-Small Cell Lung Cancer
Head and Neck Squamous Cell Carcinoma
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ABBV-514
Budigalimab
ABBV-706, Budigalimab, Cisplatin, CarboplatinStudy to Evaluate Adverse Events, Change in Disease Activity, and How ABBV-706 Moves Through the Body When Intravenously (IV) Infused Alone or in Combination With IV Infused Budigalimab, Cisplatin, or Carboplatin in Adult Participants With Advanced Solid Tumors
Sponsor:
AbbVie
Location:
Code:
NCT05599984
Conditions
Advanced Solid Tumors
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
ABBV-706
Cisplatin
Budigalimab
Carboplatin